The DOI matches its Crossref record; 26 of the 29 references it cites were found in a registry or an index.
Pattern of use and subjective effects of Salvia divinorum among recreational users
Abstract
Background Salvia divinorum is a member of the Lamiaceae family and contains the psychotropic diterpene and kappa-opioid receptor agonist salvinorin-A. Originally a shamanic inebriant used by the Mexican Mazatec Indians, the plant and its preparations are becoming increasingly popular among non-traditional users.Methods Demographic data and information on pattern of use and subjective effects were obtained by means of self-report questionnaires from a sample of 32 recreational users of salvia and other psychedelics.Results Involvement with salvia appeared to be a recent phenomenon. Smoking the extract was the preferred form of administration. Subjective effects were described as intense but short-lived, appearing in less than 1 min and lasting 15 min or less. They included psychedelic-like changes in visual perception, mood and somatic sensations, and importantly, a highly modified perception of external reality and the self, leading to a decreased ability to interact with oneself or with one's surroundings.Conclusions Although some aspects of the subjective effects reported were similar to high doses of classical psychedelics with serotonin-2A receptor agonist activity, the intense derealization and impairment reported appear to be a characteristic of salvia. The observed simultaneous high scores on the LSD and PCAG subscales of the Addiction Research Center Inventory (ARCI) have been previously reported for other kappa-opioid agonists, and support kappa receptor activation as the probable pharmacologic mechanism underlying the modified state of awareness induced by salvia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kappa receptor agonists induce anxiogenic and dysphoric effects in humans (141-143) and depressive-like behavior in animals (i.e., increased immobility in the forced swim test) (144, 145).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [142]
Citations
Cites
(1970) · Cited by 24,983
Martin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784
The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
Self-citationRiba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303
Self-citationSalvia divinorum and salvinorin A: new pharmacologic findings
Siebert, D. J. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)90116-3 · Cited by 280
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Walsh, S., Strain, E., Abreu, M., & Bigelow, G. (2001) · Psychopharmacology · doi:10.1007/s002130100788 · Cited by 258
Research works printed but not linked: 2
- Ott, 1995, Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A, Curare, 18, 103
- Wasson, 1962, vol. 20
Cited by
Sorted by citations
Items 101–165 of 165
Lin, P.-X., Li, J., Chen, S., Chang, H., & McKetin, R. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.017 · Cited by 13
A Report of Nausea and Vomiting with Discontinuation of Chronic Use ofSalvia divinorum
Travis, C. R., Ray, G. A., & Marlowe, K. F. (2012) · Case Reports in Medicine · doi:10.1155/2012/543747 · Cited by 12
Moreira, F., Carvalho, F. D., Bastos, M. D. L., & de Pinho, P. G. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.07.009 · Cited by 12
Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans
Johnson, M. W., MacLean, K. A., Caspers, M. J., Prisinzano, T. E., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116629125 · Cited by 12
A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State
Kuypers, K. P. C., Perna, E. B. D. S. F., Theunissen, E. L., Toennes, S. W., Mason, N. L., Hutten, N. R. P. W., & Ramaekers, J. G. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1569286 · Cited by 13
(2008) · CRC Press eBooks · doi:10.1201/9780849378812.ch6 · Cited by 12
Fatur, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245022 · Cited by 11
Novel neoclerodane diterpene derivatives from the smoke of salvinorin A
Ma, Z., Deng, G., & Lee, D. Y. W. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.07.144 · Cited by 11
Toward a phenomenology of urge to drink: a future prospect for the cue-reactivity paradigm
Rock, A. J., & Kambouropoulos, N. (2007) · Deakin Research Online (Deakin University) · Cited by 10
Salvinorin A and Related Compounds as Therapeutic Drugs for Psychostimulant-Related Disorders
SANTOS, R. G. D., Crippa, J. A. S., Machado‐de‐Sousa, J. P., & Hallak, J. E. C. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107122741 · Cited by 10
Thermal degradation products derived from the smoke of Salvia divinorum leaves
Ma, Z., Deng, G., Dai, R., Xu, W., Liu‐Chen, L., & Lee, D. Y. W. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.08.033 · Cited by 10
Sarkoohi, P., Fathalipour, M., Ghasemi, F. S., Javidnia, K., & Emamghoreishi, M. (2019) · Shiraz E-Medical Journal · doi:10.5812/semj.91276 · Cited by 10
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
Bouso, J. C., Oña, G., Kohek, M., SANTOS, R. G. D., Hallak, J. E. C., Alcázar‐Córcoles, M. Á., & Obiols‐Llandrich, J. (2023) · Culture Medicine and Psychiatry · doi:10.1007/s11013-022-09814-0 · Cited by 15
Self-citationRevision of Salvia subg. Calosphace sect. Membranaceae (Lamiaceae)
González‐Gallegos, J. G. (2014) · Telopea · doi:10.7751/telopea20147483 · Cited by 9
Ghosh, A., & Ghosh, T. (2010) · Systematic Reviews in Pharmacy · doi:10.4103/0975-8453.75060 · Cited by 9
Meyer, E. G., & Writer, B. W. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.07.003 · Cited by 9
Chapter 18 Toxicological aspects of herbal remedies
BOGUSZ, M. J., & Al-Tufail, M. A. (2007) · Handbook of analytical separations · doi:10.1016/s1567-7192(06)06018-9 · Cited by 9
Cytotoxic Effects of Salvinorin A, A Major Constituent of Salvia divinorum
Martinho, A., Silva, S. M., & Gallardo, E. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151005105617 · Cited by 8
Salvia Divinorum : Toxicological Aspects and Analysis in Human Biological Specimens
Margalho, C., Corte-Real, F., López‐Rivadulla, M., & Gallardo, E. (2016) · Bioanalysis · doi:10.4155/bio-2016-0067 · Cited by 7
Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence
Karam, A., Said, A., Assaad, C., Hallit, S. R., Haddad, G., Hachem, D., & Kazour, F. (2018) · Community Mental Health Journal · doi:10.1007/s10597-018-0347-4 · Cited by 8
Kappa opioid receptor control of motivated behavior revisited
Farahbakhsh, Z. Z., & Siciliano, C. A. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02226-9 · Cited by 8
Drugs of Abuse and the Internet
Arbo, M. D., Bulcão, R., Rossato, L. G., Callegari, E., Cendron, L. H., Cabrera, E., de Freitas, M. A., & Leal, M. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00005-5 · Cited by 6
Breton, J., Huỳnh, C., Raymond, S., Labelle, R. J., Bonnet, N., Cohen, D., & Guilé, J.-M. (2010) · Journal of Substance Use · doi:10.3109/14659890903060167 · Cited by 6
That deep internal voice: Controlled administration of Salvia divinorum
Addy, P. H. (n.d.) · ProQuest Demo Repository · Cited by 6
Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness
Studerus, E. (2012) · University of Zurich · doi:10.5167/uzh-164092 · Cited by 6
Optimal drug use and rational drug policy
Miller, G. F. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11000756 · Cited by 5
Salvia divinorum: enigma psicofarmacológico y resquicio mente-cuerpo
Díaz, J. L. (2014) · Salud Mental · doi:10.17711/sm.0185-3325.2014.022 · Cited by 5
“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users
Hutton, F., Kivell, B. M., & Boyle, O. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1179376 · Cited by 5
NPS: Moving from Blanket Prohibition to a Functionalist Approach
Corazza, O., Chan, H. Y., & Román-Urrestarazu, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-60600-2_9 · Cited by 5
Baird, T. R., Davies, R. A., Glennon, R. A., Peace, M. R., & Negus, S. S. (2021) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2021.100004 · Cited by 5
Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species
Hatıpoğlu, S. D., Yalçınkaya, B., Akgöz, M., Öztürk, T., Gören, A. C., & Topçu, G. (2017) · Phytochemical Analysis · doi:10.1002/pca.2703 · Cited by 5
A Content Analysis of Salvia Divinorum Use on YouTube
Paterline, B. A., & Albo, M. J. (2013) · The Journal of Public and Professional Sociology · doi:10.62915/2154-8935.1055 · Cited by 4
Salles, J., Ponté, C., & Schmitt, L. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1574367 · Cited by 4
Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents
Carlini, E. A., & Maia, L. O. (2019) · Toxinology · doi:10.1007/978-94-007-6728-7_6-2 · Cited by 4
[Psychoactive plant species--actual list of plants prohibited in Poland].
Simonienko, K., Waszkiewicz, N., & Szulc, A. (2013) · PubMed · Cited by 4
Schneider, R., & Ardenghi, P. (2010) · Revista Brasileira de Plantas Medicinais · doi:10.1590/s1516-05722010000300014 · Cited by 3
Case Studies of Emerging Drugs: Salvia, Bath Salts, and Bromo-DragonFly
Khey, D. N., Stogner, J. M., & Miller, B. L. (2013) · SpringerBriefs in criminology · doi:10.1007/978-3-319-03575-8_4 · Cited by 2
Salvia divinorum, Hallucinogens, and the Determination of Medical Utility
Griffin, O. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-40957-8_8 · Cited by 2
Update of the Altered States Database (ASDB): 2022-12-31Preprint
Peters, M., Prugger, J., Dimkov, P. R., & Schmidt, T. T. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/wdfhg · Cited by 3
Neuropeptide Receptors: Novel Therapeutic Targets for Depression and Anxiety Disorders
Chaki, S., & Kanuma, K. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00300 · Cited by 1
Manic Episode with Psychotic Features Associated with Salvia divinorum Use: A Case Report
Lin, Z.-Y., & Huang, M. (2024) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_27_24 · Cited by 1
Predicting the emergence of novel psychoactive substances with big data
Perdue, R. T., & E.Hawdon, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822884-5.00014-3 · Cited by 1
Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents
Carlini, E. A., & Maia, L. O. (2015) · Springer eBooks · doi:10.1007/978-94-007-6728-7_6-1 · Cited by 1
Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter
Simonson, B. (2011) · doi:10.26686/wgtn.16985389.v1 · Cited by 2
Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands
Smith, K. M. (2012) · KU ScholarWorks (The University of Kansas) · Cited by 1
Alterations in The States and Contents of Consciousness: Empirical and Theoretical Aspects
Noreika, V. (2014) · UTUPub (University of Turku) · Cited by 1
The Efficacy of PRISTINE: Revealing Concealed Opioid Crisis Trends via Reddit ExaminationPreprint
Alhamadani, A., Sarkar, S., Behal, S., Alkulaib, L., & Lu, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2758553/v1 · Cited by 1
Potential Utility of Kappa Ligands in the Treatment of Mood Disorders
Carlezon, W. A., & Cohen, B. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_22 · Cited by 1
Salvia divinorum Epling & Jativa and Salvinorin A
Barceloux, D. G. (2012) · doi:10.1002/9781118105955.ch65
Psychoactive substances present in Salvia divinorum acquired in smartshops or in the Internet
Moreira, F. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/ebfs-x653
Identification and characterization of diterpene synthases in the salvinorin A biosynthetic pathway
Mitchell, R. (2012) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26417
Behavioral and Psychological Effects of Salvia divinorum
Addy, P. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00068-6
Opioid Modulation of Voltage-Gated Calcium Currents
Soto, E., Seseña, E., & Vega, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00046-9
Investigations Of Salvinorin A: Synthetic Isolation, Quantification, And In Vivo Characteristics
Caspers, M. (2013) · KU ScholarWorks (The University of Kansas)
Wong, L., Stevens, S., Hengel, M. J., & Shibamoto, T. (2018) · Advances in Recycling & Waste Management · doi:10.4172/2475-7675.1000305
Gross, J. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4060
Geschwinde, T. (2018) · Springer eBooks · doi:10.1007/978-3-662-56275-8_1
Geschwinde, T. (2012) · Springer eBooks · doi:10.1007/978-3-642-30163-6_1
Nava-Gomez, L. J., & González-González, J. C. (2022) · Revista Iberoamericana ConCiencia. · doi:10.32654/concienciaepg/eds.especial-9
Bello, E. (2022) · Cadernos de Campo (São Paulo 1991) · doi:10.11606/issn.2316-9133.v31i1pe197817
Beyond the high: Exploring addiction to non-psychoactive substances
Kumar, J., Shaan, F., Naik, P. K., Reyazuddin, M., & Ahsan, M. (2025) · Archives of Biological Psychiatry · doi:10.25259/abp_16_2024
Шагиахметов, Ф. Ш., Krupitsky, E. M., Shamakina, I. Y., Anokhin, P. K., Arkus, M. L., & Scheidegger, Y. M. (2026) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2026-1-1179
Ross, B. M. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00517
BindingDB (2011) · UC San Diego · doi:10.7270/q2s182qc
Metadata
- Authors
- González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J.
- Affiliations
- Universidad Autónoma de Madrid (ES)
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- Barbanoj, Manel J.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 85
- Issue
- 2
- Pages
- 157-162
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2168830964
- Cited by
- 163
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 19
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- Salvia divinorum, salvinorin A, kappa opioid receptor agonists, recreational drug use, subjective effects, derealization, psychedelic effects, Addiction Research Center Inventory
- MeSH terms
- Adult, Affect, Cross-Sectional Studies, Diterpenes, Euphoria, Female, Humans, Male, Perception, Plant Extracts, Reality Testing, Retrospective Studies, Sensation, Spain, Illicit Drugs, Receptors, Opioid, kappa, Substance-Related Disorders, Salvia, Diterpenes, Clerodane
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review